Table 2.
Comparison of inherited thrombophilia in tested patients with mesenteric venous thrombosis versus systemic VTE
| Variable | MVT | Systemic VTE | p value |
|---|---|---|---|
| Number of patients | 120 | 1452 | |
| Heterozygous FVL mutation (%) | 19/89 (21.3) | 348/1021 (34.1) | 0.014 |
| Homozygous FVL mutation (%) | 3/89 (3.4) | 36/1021 (3.5) | 0.94 |
| FVL mutation (any) (%) | 22/89 (24.7) | 384/1021 (37.6) | 0.015 |
| FVL mutation (any) without malignancy (%) | 21/79 (26.6) | 360/926 (38.9) | 0.031 |
| Heterozygous PT mutation (%) | 3/89 (3.4) | 58/1259 (4.6) | 0.79 |
| Homozygous PT mutation (%) | 0/89 (0.0) | 0/1259 (0.0) | – |
| PT mutation (any) (%) | 3/89 (3.4) | 58/1259 (4.6) | 0.79 |
| Compound FVL and PT mutation (%) | 0/89 (0.0) | 11/1245 (0.9) | 1.0 |
| FVL or PT mutation (any) (%) | 25/89 (28.1) | 429/1036 (41.4) | 0.014 |
| No FVL or PT mutation (%) | 64/89 (72.0) | 605/1036 (58.4) | 0.013 |
FVL Factor V Leiden, PT prothrombin